Toronto, Ontario - November 18th, 2020 - conversationHEALTH, the conversational AI platform for the life sciences industry is honoured to receive Deloitte's Companies-to-Watch award. The award spotlights emerging companies that exhibit strong growth and show potential to be a future candidate of the Technology Fast 50 award.
conversationHEALTH’s CEO and Founder, Dr. John Reeves, notes “We are proud to be named one of Canada’s Companies-to-Watch technology companies in this year’s Technology Fast 50™ program. This achievement is a true testament to the vision of the company and the dedication of our people who strive to make us a conversational AI leader globally. We are now working with 20 global life sciences companies, in North America, Europe and Asia, transforming how these companies engage with health professionals, patients and consumers. We expect to sustain this pace of growth throughout 2021 as more global life sciences companies conversationalize their businesses and brands, and build out self-service capabilities to meet the needs of their customers 24/7/365”.
Companies-to-Watch winners are new companies headquartered in Canada, demonstrating superior technology, effective management experience and common traits of Deloitte Technology Fast 50 award winners. To be eligible, candidates must also devote a significant portion of their operating revenues to creating proprietary technology or intellectual property.
“Companies-to-Watch winners deserve recognition for their early stage growth, bold entrepreneurship and forward thinking,” said Erica Pretorius, Partner and National Leader for the Technology Fast 50™ program at Deloitte Canada. “By demonstrating courage, seeking opportunities, and taking calculated risks, these outstanding companies are key to the success of the technology sector. Every winner should feel a sense of pride for this success, and motivation to continue striving to succeed in the future.”
About the Deloitte Technology Fast 50™
The Deloitte Technology Fast 50 program is Canada’s pre-eminent technology awards program. Celebrating business growth, innovation and entrepreneurship, the program features distinct categories, including the Technology Fast 50 ranking, Enterprise Fast 15, and Companies-to-Watch. The program also recognizes companies within the North American Technology Fast 500 ranking, identifying technology companies in the United States and Canada. The 2020 program sponsors include Deloitte, RBC, CBRE, Clarity Recruitment, and Lafond. For further information, visit www.fast50.ca.
Deloitte provides audit and assurance, consulting, financial advisory, risk advisory, tax, and related services to public and private clients spanning multiple industries. Deloitte serves four out of five Fortune Global 500® companies through a globally connected network of member firms in more than 150 countries and territories bringing world-class capabilities, insights, and service to address clients’ most complex business challenges. Deloitte LLP, an Ontario limited liability partnership, is the Canadian member firm of Deloitte Touche Tohmatsu Limited. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.
Our global Purpose is making an impact that matters. At Deloitte Canada, that translates into building a better future by accelerating and expanding access to knowledge. We believe we can achieve this Purpose by living our shared values to lead the way, serve with integrity, take care of each other, foster inclusion, and collaborate for measurable impact.
To learn more about how Deloitte’s approximately 312,000 professionals, over 12,000 of whom are part of the Canadian firm, please connect with us on LinkedIn, Twitter, Instagram, or Facebook.
conversationHEALTH is a team of life sciences experts, artificial intelligence engineers, software developers, data scientists and conversational architects that, together, are building industry-changing conversational AI solutions. The conversationHEALTH SaaS platform is purpose-built for the life sciences industry and sets the standard in terms of accuracy and compliance due to medically-trained taxonomies, data sets, and healthcare specific NLP engine. The platform also integrates with all major software providers in the life sciences industry, who are deploying conversational agents in clinical trials, medical affairs, and commercial lines of business.
conversationHEALTH is based in Toronto, Canada with offices in North America and in Europe. For more information, visit conversationhealth.com
For media enquiries:
Director of Marketing